These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 30631910)

  • 1. Comparison of image quality and lesion detection between digital and analog PET/CT.
    López-Mora DA; Flotats A; Fuentes-Ocampo F; Camacho V; Fernández A; Ruiz A; Duch J; Sizova M; Domènech A; Estorch M; Carrió I
    Eur J Nucl Med Mol Imaging; 2019 Jun; 46(6):1383-1390. PubMed ID: 30631910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Digital vs. analog PET/CT: intra-subject comparison of the SUVmax in target lesions and reference regions.
    Fuentes-Ocampo F; López-Mora DA; Flotats A; Paillahueque G; Camacho V; Duch J; Fernández A; Domènech A; Estorch M; Carrió I
    Eur J Nucl Med Mol Imaging; 2019 Jul; 46(8):1745-1750. PubMed ID: 30617960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Digital versus analog PET/CT in patients with known or suspected liver metastases.
    Fuentes-Ocampo F; López-Mora DA; Flotats A; Camacho V; Sizova M; Abouzian S; Duch J; Fernández A; Estorch M; Carrió I
    Nucl Med Commun; 2021 Apr; 42(4):421-428. PubMed ID: 33306635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Digital PET/CT allows for shorter acquisition protocols or reduced radiopharmaceutical dose in [
    Alberts I; Sachpekidis C; Prenosil G; Viscione M; Bohn KP; Mingels C; Shi K; Ashar-Oromieh A; Rominger A
    Ann Nucl Med; 2021 Apr; 35(4):485-492. PubMed ID: 33550515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated whole-body PET/MR hybrid imaging: clinical experience.
    Quick HH; von Gall C; Zeilinger M; Wiesmüller M; Braun H; Ziegler S; Kuwert T; Uder M; Dörfler A; Kalender WA; Lell M
    Invest Radiol; 2013 May; 48(5):280-9. PubMed ID: 23442775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimizing positron emission tomography image acquisition protocols in integrated positron emission tomography/magnetic resonance imaging.
    Hartung-Knemeyer V; Beiderwellen KJ; Buchbender C; Kuehl H; Lauenstein TC; Bockisch A; Poeppel TD
    Invest Radiol; 2013 May; 48(5):290-4. PubMed ID: 23399811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PET/MRI with diagnostic MR sequences vs PET/CT in the detection of abdominal and pelvic cancer.
    Xin J; Ma Q; Guo Q; Sun H; Zhang S; Liu C; Zhai W
    Eur J Radiol; 2016 Apr; 85(4):751-9. PubMed ID: 26971419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Image Quality and Diagnostic Performance of a Digital PET Prototype in Patients with Oncologic Diseases: Initial Experience and Comparison with Analog PET.
    Nguyen NC; Vercher-Conejero JL; Sattar A; Miller MA; Maniawski PJ; Jordan DW; Muzic RF; Su KH; O'Donnell JK; Faulhaber PF
    J Nucl Med; 2015 Sep; 56(9):1378-85. PubMed ID: 26159588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PET/MR imaging in the detection and characterization of pulmonary lesions: technical and diagnostic evaluation in comparison to PET/CT.
    Rauscher I; Eiber M; Fürst S; Souvatzoglou M; Nekolla SG; Ziegler SI; Rummeny EJ; Schwaiger M; Beer AJ
    J Nucl Med; 2014 May; 55(5):724-9. PubMed ID: 24652827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of Image Quality and Lesion Detectability With Digital PET/CT System.
    Delcroix O; Bourhis D; Keromnes N; Robin P; Le Roux PY; Abgral R; Salaun PY; Querellou S
    Front Med (Lausanne); 2021; 8():629096. PubMed ID: 33693016
    [No Abstract]   [Full Text] [Related]  

  • 12. Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system.
    Schmidt H; Brendle C; Schraml C; Martirosian P; Bezrukov I; Hetzel J; Müller M; Sauter A; Claussen CD; Pfannenberg C; Schwenzer NF
    Invest Radiol; 2013 May; 48(5):247-55. PubMed ID: 23519008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Image Quality and Semiquantitative Measurements on the Biograph Vision PET/CT System: Initial Experiences and Comparison with the Biograph mCT.
    van Sluis J; Boellaard R; Somasundaram A; van Snick PH; Borra RJH; Dierckx RAJO; Stormezand GN; Glaudemans AWJM; Noordzij W
    J Nucl Med; 2020 Jan; 61(1):129-135. PubMed ID: 31253742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The image quality, lesion detectability, and acquisition time of
    Zhang YQ; Hu PC; Wu RZ; Gu YS; Chen SG; Yu HJ; Wang XQ; Song J; Shi HC
    Eur J Nucl Med Mol Imaging; 2020 Oct; 47(11):2507-2515. PubMed ID: 32424483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Added Value of Digital over Analog PET/CT: More Significant as Image Field of View and Body Mass Index Increase.
    Hatami S; Frye S; McMunn A; Botkin C; Muzaffar R; Christopher K; Osman M
    J Nucl Med Technol; 2020 Dec; 48(4):354-360. PubMed ID: 32887763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of retrospective fusion of PET and MR images in detection of hepatic metastases: comparison with 18F-FDG PET/CT and Gd-EOB-DTPA-enhanced MRI.
    Donati OF; Hany TF; Reiner CS; von Schulthess GK; Marincek B; Seifert B; Weishaupt D
    J Nucl Med; 2010 May; 51(5):692-9. PubMed ID: 20395324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical evaluation of a block sequential regularized expectation maximization reconstruction algorithm in 18F-FDG PET/CT studies.
    Sah BR; Stolzmann P; Delso G; Wollenweber SD; Hüllner M; Hakami YA; Queiroz MA; Barbosa FG; von Schulthess GK; Pietsch C; Veit-Haibach P
    Nucl Med Commun; 2017 Jan; 38(1):57-66. PubMed ID: 27755394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of whole-body integrated 18F-FDG PET/MR in comparison to PET/CT for evaluation of malignant bone lesions.
    Eiber M; Takei T; Souvatzoglou M; Mayerhoefer ME; Fürst S; Gaertner FC; Loeffelbein DJ; Rummeny EJ; Ziegler SI; Schwaiger M; Beer AJ
    J Nucl Med; 2014 Feb; 55(2):191-7. PubMed ID: 24309383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of 18F-fluoride PET/MR and PET/CT in patients with foot pain of unclear cause.
    Rauscher I; Beer AJ; Schaeffeler C; Souvatzoglou M; Crönlein M; Kirchhoff C; Sandmann G; Fürst S; Kilger R; Herz M; Ziegler S; Schwaiger M; Eiber M
    J Nucl Med; 2015 Mar; 56(3):430-5. PubMed ID: 25678485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic performance of
    Chaput A; Robin P; Podeur F; Ollivier M; Keromnes N; Tissot V; Nonent M; Salaün PY; Rousset J; Abgral R
    Laryngoscope; 2018 Feb; 128(2):378-385. PubMed ID: 28600822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.